Literature DB >> 24129086

Advances in the quantification of relevant allergens in allergenic extracts.

T Batard1, E Nony, M Hrabina, H Chabre, F Frati, P Moingeon.   

Abstract

Relevant allergens are major contributors to the safety and efficacy of allergenic extracts used in allergen immunotherapy (AIT). As such, they should be accurately quantified, as recommended by the 2008 European guidelines on allergen products. Until now, the quantification of relevant allergens was mainly performed by using immunoassays (e.g. ELISA) that relying upon specific antibodies. Although antibody-based quantification is commonly used to assess the concentration of relevant allergens in allergenic extracts, results must be taken with caution in the light of the inherent limitations of such techniques. In the present study, we discuss how those limitations can be overcome by using comprehensive mass spectrometry-based techniques.

Mesh:

Substances:

Year:  2013        PMID: 24129086

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  3 in total

Review 1.  Standardization and Regulation of Allergen Products in the European Union.

Authors:  Julia Zimmer; Stefan Vieths; Susanne Kaul
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

2.  Evaluation of a sublingual immunotherapy solution in olive-induced respiratory allergy in Jordan: a retrospective observational study.

Authors:  Khaled Al-Asad; Sayed Al-Nazer; Anan Al-Faqih; Mohammad Jamil Hashem
Journal:  J Asthma Allergy       Date:  2017-02-24

Review 3.  New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis.

Authors:  Franco Frati; Lorenzo Cecchi; Enrico Scala; Erminia Ridolo; Ilaria Dell'Albani; Eleni Makrì; Giovanni Pajno; Cristoforo Incorvaia
Journal:  Biologics       Date:  2014-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.